Specifically, we identified CpGs that were differentially methylated between estrogen receptor positive (ER+) and estrogen receptor negative (ER-) breast cancer samples in TCGA data using a Student’s t-test, and then examined the occurrences of putative TF binding motifs within DNA regions surrounding these CpGs. The gene discussed is TF; the disease is breast carcinoma.